Purpose: To correlate intestinal contrast enhancement and wall thickening with the degree of inflammation in an experimental model of inflammatory bowel disease.
Materials and Methods:Inflammatory bowel disease was elicited in 39 New Zealand White rabbits by rectal instillation of 2,4,6-trinitrobenzene sulphonic acid (TNBA). Magnetic resonance imaging (MRI) was used to determine bowel wall thickness and intestinal contrast enhancement after the administration of 0.1 mmol/kg of gadodiamide intravenously. MR measurements were compared with the complete histopathologic analysis.Results: MR measurements of bowel wall thickness correlated well with histopathologic measurements in vitro (r ϭ 0.85, P Ͻ 0.0001) and with histopathologic evidence of chronic inflammatory bowel disease (P Ͻ 0.02). Chronic inflammation was characterized by increased intestinal contrast enhancement (137 Ϯ 25%) when compared to normal bowel (86 Ϯ 7%, P ϭ 0.04).
Conclusion:Contrast-enhanced MRI accurately reflects inflammatory bowel disease in the rabbit model.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.